{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:21:11Z","timestamp":1777418471063,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[1995,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To review the clinical pharmacology of torsemide and to compare it with currently available loop diuretics, particularly furosemide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>An English-language MEDLINE search, 1985 to October 1994, was used to identify pertinent literature, including review articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction:<\/jats:title>\n                    <jats:p>Data from scientific literature were extracted, evaluated, and summarized for presentation. Pivotal and representative studies are discussed relating to the pharmacology, pharmacokinetics, and use of torsemide in patients with congestive heart failure, renal disease, hepatic disease, and hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Torsemide is a loop diuretic of the pyridine-sulfonylurea class. The bioavailability of torsemide is approximately 80%, with little first-pass metabolism, and torsemide can be given without regard to meals. The serum concentration reaches its peak within 1 hour after oral administration and diuresis lasts approximately 6\u20148 hours. Torsemide is eliminated both hepatically (80%) and renally (20%) as unchanged drug with an elimination half-life of about 3.5 hours. Because of the high bioavailability, oral and intravenous doses are therapeutically equivalent. Torsemide, and other loop diuretics such as furosemide, are indicated for the treatment of edema associated with congestive heart failure, renal disease, and hepatic disease. They also are indicated for the treatment of hypertension alone or in combination with other antihypertensive agents. Depending on the indication, the recommended initial adult dosage of torsemide is between 5 and 20 mg once daily orally or intravenously. Special dosage adjustments in the elderly are not necessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Torsemide is a loop diuretic similar to furosemide, with similar indications. Torsemide is characterized by good bioavailability and once-daily dosing and, compared with furosemide, provides generally equivalent therapeutic efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/106002809502900411","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T22:59:14Z","timestamp":1484175554000},"page":"396-402","source":"Crossref","is-referenced-by-count":23,"title":["Torsemide: A Pyridine-Sulfonylurea Loop Diuretic"],"prefix":"10.1177","volume":"29","author":[{"given":"Jamie S","family":"Blose","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Kirkwood F","family":"Adams","sequence":"additional","affiliation":[{"name":"Heart Failure Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Herbert","family":"Patterson","sequence":"additional","affiliation":[{"name":"Research Associate Professor of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1995,4,1]]},"reference":[{"key":"bibr1-106002809502900411","first-page":"1532","volume":"35","author":"Hermes H","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"bibr2-106002809502900411","first-page":"151","volume":"38","author":"Greger R.","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr3-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582640"},{"key":"bibr4-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541462"},{"key":"bibr5-106002809502900411","volume-title":"Package insert","year":"1993"},{"key":"bibr6-106002809502900411","first-page":"160","volume":"38","author":"Lesne M.","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr7-106002809502900411","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199100413-00004"},{"key":"bibr8-106002809502900411","first-page":"172","volume":"38","author":"Dupont AG","year":"1988","journal-title":"Arneimittelforschung"},{"key":"bibr9-106002809502900411","first-page":"29","volume":"8","author":"Barr WH","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr10-106002809502900411","first-page":"261","author":"Spieker W","year":"1986","journal-title":"Diuretics: basic, pharmacological, and clinical aspects"},{"key":"bibr11-106002809502900411","first-page":"164","volume":"38","author":"Neugebauer G","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr12-106002809502900411","first-page":"15","volume":"8","author":"Barr WH","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr13-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.116"},{"key":"bibr14-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.98"},{"key":"bibr15-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.131"},{"key":"bibr16-106002809502900411","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141010-00008"},{"key":"bibr17-106002809502900411","first-page":"73","volume":"8","author":"Von Moellendorff E","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr18-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541468"},{"key":"bibr19-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541465"},{"key":"bibr20-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90489-8"},{"key":"bibr21-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1994.tb02848.x"},{"key":"bibr22-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.100"},{"key":"bibr23-106002809502900411","first-page":"105","volume":"8","author":"Duesing R","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr24-106002809502900411","first-page":"121","volume":"8","author":"Stauch M","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr25-106002809502900411","first-page":"1051","volume":"15","author":"Goebel KM","year":"1993","journal-title":"Clin Ther"},{"key":"bibr26-106002809502900411","first-page":"127","volume":"8","author":"Achhammer I.","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr27-106002809502900411","first-page":"184","volume":"38","author":"Achhammer I","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr28-106002809502900411","first-page":"147","volume":"8","author":"Langbehn AF","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr29-106002809502900411","first-page":"97","volume":"8","author":"Fiehring H","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr30-106002809502900411","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199100413-00007"},{"key":"bibr31-106002809502900411","first-page":"157","volume":"8","author":"Podszus T","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr32-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.99"},{"key":"bibr33-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1159\/000185942"},{"key":"bibr34-106002809502900411","first-page":"205","volume":"38","author":"Mourad G","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr35-106002809502900411","first-page":"209","volume":"38","author":"Clasen W","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr36-106002809502900411","first-page":"259","volume":"8","author":"Stolear IC","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr37-106002809502900411","first-page":"249","volume":"8","author":"Schulz W","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr38-106002809502900411","first-page":"27","volume-title":"Diuretics IV: chemistry, pharmacology, and clinical applications","author":"Brunner G","year":"1993"},{"key":"bibr39-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840130616"},{"key":"bibr40-106002809502900411","first-page":"396","volume-title":"Diuretics III: chemistry, pharmacology, and clinical applications","author":"Crippa G","year":"1990"},{"key":"bibr41-106002809502900411","first-page":"169","volume":"8","author":"Baumgart P","year":"1990","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"bibr42-106002809502900411","first-page":"50","volume-title":"Diuretics II: chemistry, pharmacology and clinical applications","author":"Haecker W","year":"1987"},{"key":"bibr43-106002809502900411","first-page":"80","volume":"41","author":"Achhammer I","year":"1991","journal-title":"Experience with torasemide"},{"key":"bibr44-106002809502900411","first-page":"153","volume":"38","author":"Klinke R","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"bibr45-106002809502900411","first-page":"66","volume-title":"Diuretics III: chemistry, pharmacology, and clinical applications","author":"Kraemer BK","year":"1990"},{"key":"bibr46-106002809502900411","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0022-3565(25)24138-6","volume":"248","author":"Herchuelz A","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr47-106002809502900411","first-page":"361","volume-title":"Diuretics IV: chemistry, pharmacology and clinical applications","author":"Kramer WG","year":"1993"},{"key":"bibr48-106002809502900411","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb05757.x"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809502900411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809502900411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:07:10Z","timestamp":1777374430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809502900411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1177\/106002809502900411"],"URL":"https:\/\/doi.org\/10.1177\/106002809502900411","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}